Ramiprilaat (standaard)

Alvimopan (dihydrate) (Standard) is the analytical standard of Alvimopan (dihydrate) . This product is intended for research and analytical applications. Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively) . Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].

87269-97-4

HOE 498 diacid (Standard) ; Ramipril diacid (Standard)

12352005

H302, H315, H319, H335

Angiotensin-converting Enzyme (ACE) ; Drug Metabolite; Endogenous Metabolite; Reference Standards

Metabolic Enzyme/Protease; Others

Cardiovascular Disease

96.61

O=C([C@@H]1C[C@@](CCC2)([H])[C@@]2([H])N1C([C@@H](N[C@H](C(O)=O)CCC3=CC=CC=C3)C)=O)O

C21H28N2O5

388.46

H302, H315, H319, H335

Angiotensin converting enzyme (ACE) [1]

Blue Ice

-20°C, sealed storage, away from light and moisture

http://file.medchemexpress.com/batch_PDF/HY-A0115R/Ramiprilat-Standard-SDS-MedChemExpress.pdf

Reference Standards